Prospective comparison of sodium hyaluronate and hylan G-F 20 in a clinical practice: Comment on the concise communication by Martens [3] (multiple letters)

Arthritis and Rheumatism

Volumn 50, Issue 5, 2004, Pages 1697-1698

  Brown, Daniel J ^a   Wood, Edward V ^b   Hannah, Hayley M ^c   Rao, Vadlamani S ^d   Teanby, David ^a   Martens, Peter B ^a  

^a Whiston and St Helens Hospital   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c Queens Hospital ^*

^d S Shore Int Medicine Associates   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARTZAL; HYALURONIC ACID;

ARTHROCENTESIS; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; LETTER; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; HYALURONIC ACID; OSTEOARTHRITIS, KNEE; PROSPECTIVE STUDIES;

EID: 2342557045     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20182     Document Type: Letter

References (0)